{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:06:45Z","timestamp":1792260405044,"version":"4.4.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejca.2023.113254","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T17:51:49Z","timestamp":1690566709000},"page":"113254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":293,"special_numbering":"C","title":["European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma\u2014update 2023"],"prefix":"10.1016","volume":"192","author":[{"given":"Ketty","family":"Peris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Arenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5478-9826","authenticated-orcid":false,"given":"Lars","family":"Bastholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Basset","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Brochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-7883","authenticated-orcid":false,"given":"Ana-Marie","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gaudy-Marqueste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Kandolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole W.J.","family":"Kellerners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8019-1577","authenticated-orcid":false,"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-1719","authenticated-orcid":false,"given":"Zeljko","family":"Mijuskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Nagore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eggert","family":"Stockfleth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-0982","authenticated-orcid":false,"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Trakatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-4955","authenticated-orcid":false,"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-780X","authenticated-orcid":false,"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2023.113254_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","article-title":"Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines","volume":"118","author":"Peris","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/bjd.20524","article-title":"British Association of Dermatologists\u2019 Clinical Standards Unit. British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021","volume":"185","author":"Nasr","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib3","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.ejca.2023.113254_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ncb2031","article-title":"Identification of the cell lineage at the origin of basal cell carcinoma","volume":"12","author":"Youssef","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.ejca.2023.113254_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccr.2010.11.007","article-title":"Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+\/-) mice","volume":"19","author":"Wang","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2023.113254_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.stem.2015.02.006","article-title":"Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches","volume":"16","author":"Peterson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ejca.2023.113254_bib7","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib8","first-page":"120","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejca.2023.113254_bib9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib10","first-page":"303","article-title":"Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J\u00a0Am\u00a0Acad\u00a0Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib11","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3495","article-title":"Update in the management of basal cell carcinoma","volume":"100","author":"Basset-Seguin","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/jdv.18774","article-title":"Basal cell carcinoma: epidemiological impact of clinical versus histopathological diagnosis","volume":"37","author":"Backman","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jid.2008.234","article-title":"Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population","volume":"129","author":"Richmond-Sinclair","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1751-1097.2010.00735.x","article-title":"Basal cell carcinoma: what's new under the sun","volume":"86","author":"Dessinioti","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ejca.2023.113254_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bjd.15321","article-title":"Epidemiology of basal cell carcinoma: scholarly review","volume":"177","author":"Verkouteren","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ijc.25411","article-title":"Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women","volume":"127","author":"Birch-Johansen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/bjd.20964","article-title":"Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study","volume":"186","author":"Kappelin","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bjd.20871","article-title":"A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence","volume":"186","author":"Schreuder","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2017.11.026","article-title":"All-cause mortality in patients with basal and squamous cell carcinoma: a systematic review and meta-analysis","volume":"78","author":"Wehner","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib20","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib21","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1038\/jid.2015.244","article-title":"Predicting the risk of a second basal cell carcinoma","volume":"135","author":"Verkouteren","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2017.02.047","article-title":"Correlates of multiple basal cell carcinoma in a retrospective cohort study: sex, histologic subtypes, and anatomic distribution","volume":"77","author":"Kuo","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib23","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1111\/jdv.16512","article-title":"High-frequency basal cell carcinoma in Danish patients: prevalence and consistency","volume":"34","author":"Saldanha","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jaad.2020.07.088","article-title":"Prevalence and risk factors for high-frequency basal cell carcinoma in the United States","volume":"84","author":"Chiang","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2016.06.020","article-title":"Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: a retrospective cohort study","volume":"75","author":"Goldenberg","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/PAP.0000000000000267","article-title":"Metastatic basal cell carcinoma of the skin: a comprehensive literature review, including advances in molecular therapeutics","volume":"27","author":"Bisceglia","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ejca.2023.113254_bib27","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/bjd.13217","article-title":"Basal cell carcinomas in a tertiary referral centre: a systematic analysis","volume":"171","author":"Dreier","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2023.113254_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2023.113254_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/ijms18112485","article-title":"Understanding the molecular genetics of basal cell carcinoma","volume":"18","author":"Pellegrini","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2023.113254_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5909","article-title":"Indoor tanning and non-melanoma skin cancer: systematic review and meta-analysis","volume":"345","author":"Wehner","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2023.113254_bib32","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.3390\/cancers13235940","article-title":"Indoor tanning and the risk of overall and early-onset melanoma and non-melanoma skin cancer: systematic review and meta-analysis","volume":"13","author":"An","year":"2021","journal-title":"Cancers ((Basel))"},{"key":"10.1016\/j.ejca.2023.113254_bib33","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.3390\/curroncol29110699","article-title":"An epidemiological update on indoor tanning and the risk of skin cancers","volume":"29","author":"Dessinioti","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.2015.231","article-title":"MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project","volume":"113","author":"Tagliabue","year":"2015","journal-title":"Br J Cancer"},{"issue":"5952","key":"10.1016\/j.ejca.2023.113254_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejca.2023.113254_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jid.2021.06.020","article-title":"Oncogenic Hedgehog-smoothened signaling depends on YAP1\u2013TAZ\/TEAD transcription to restrain differentiation in basal cell carcinoma","volume":"142","author":"Yuan","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib37","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-21-3764","article-title":"Frequency and genomic aspects of intrinsic resistance to vismodegib in locally advanced basal cell carcinoma","volume":"28","author":"Yurchenko","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2023.113254_bib38","first-page":"1","article-title":"Immunologic characteristics of nonmelanoma skin cancers: implications for immunotherapy","volume":"40","author":"Hall","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejca.2023.113254_bib39","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.3390\/cancers14194547","article-title":"Long-term management of advanced basal cell carcinoma: current challenges and future perspectives","volume":"14","author":"Heppt","year":"2022","journal-title":"Cancers ((Basel))"},{"key":"10.1016\/j.ejca.2023.113254_bib40","first-page":"1159","article-title":"Xeroderma pigmentosum - facts and perspectives","volume":"38","author":"Lehmann","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2023.113254_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ijd.14065","article-title":"Bazex-Dupr\u00e9-Christol syndrome: review of clinical and molecular aspects","volume":"57","author":"AlSabbagh","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/bjd.21842","article-title":"Germline intergenic duplications at Xq26.1 underlie Bazex-Dupr\u00e9-Christol basal cell carcinoma susceptibility syndrome","volume":"187","author":"Liu","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6S","key":"10.1016\/j.ejca.2023.113254_bib43","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2022.03.023","article-title":"Advanced basal cell carcinoma: what dermatologists need to know about diagnosis","volume":"86","author":"Krakowski","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib44","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/jdv.17466","article-title":"Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition","volume":"35","author":"Grob","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib45","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/jdv.17467","article-title":"Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas","volume":"35","author":"Grob","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib46","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jaad.2018.12.026","article-title":"The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis","volume":"80","author":"Reiter","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib47","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2340\/00015555-2113","article-title":"Subtyping basal cell carcinoma by clinical diagnosis versus punch biopsy","volume":"95","author":"Roozeboom","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaad.2009.05.035","article-title":"Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis","volume":"62","author":"Altamura","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib49","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamadermatol.2020.1450","article-title":"Association of multiple aggregated yellow-white globules with nonpigmented basal cell carcinoma","volume":"156","author":"Navarrete-Dechent","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib50","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archdermatol.2012.2228","article-title":"The \"signature\" pattern of multiple Basal cell carcinomas","volume":"148","author":"Zalaudek","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib51","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaad.2019.11.008","article-title":"Dermoscopic features of basal cell carcinoma and its subtypes: a systematic review","volume":"85","author":"Reiter","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib52","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/jdv.12980","article-title":"Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location","volume":"29","author":"Suppa","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/bjd.14499","article-title":"Preoperative prediction of histopathological outcome in basal cell carcinoma: flat surface and multiple small erosions predict superficial basal cell carcinoma in lighter skin types","volume":"175","author":"Ahnlide","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2013.10.003","article-title":"Accuracy of dermoscopic criteria for discriminating superficial from other subtypes of basal cell carcinoma","volume":"70","author":"Lallas","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib55","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/DSS.0000000000002471","article-title":"Dermoscopic findings in the presurgical evaluation of basal cell carcinoma. A prospective study","volume":"47","author":"Conforti","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1684\/ejd.2021.4178","article-title":"How to spot a basosquamous carcinoma: a study on demographics, clinical-dermatoscopic features and histopathological correlations","volume":"31","author":"Sgouros","year":"2021","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib57","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/bjd.12394","article-title":"Dermoscopy of basosquamous carcinoma","volume":"169","author":"Giacomel","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib58","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bjd.12749","article-title":"Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma","volume":"170","author":"Apalla","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/jdv.16597","article-title":"Sclerodermiform basal cell carcinomas vs. other histotypes: analysis of specific demographic, clinical and dermatoscopic features","volume":"35","author":"Conforti","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib60","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jid.2016.02.012","article-title":"Research techniques made simple: noninvasive imaging technologies for the delineation of basal cell carcinomas","volume":"136","author":"Que","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib61","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/bjd.14244","article-title":"A new approach for presurgical margin assessment by reflectance confocal microscopy of basal cell carcinoma","volume":"174","author":"Venturini","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ced.13055","article-title":"Diagnostic accuracy of reflectance confocal microscopy using VivaScope for detecting and monitoring skin lesions: a systematic review","volume":"42","author":"Edwards","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib63","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1038\/jid.2012.172","article-title":"In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases","volume":"132","author":"Guitera","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib64","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/jdv.13224","article-title":"In vivo confocal microscopy of basal cell carcinoma: a systematic review of diagnostic accuracy","volume":"29","author":"Kadouch","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib65","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/bjd.15559","article-title":"One-stop-shop with confocal microscopy imaging vs. standard care for surgical treatment of basal cell carcinoma: an open-label, noninferiority, randomized controlled multicentre trial","volume":"177","author":"Kadouch","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib66","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1468-3083.2010.03871.x","article-title":"Non-invasive management of non-melanoma skin cancer in patients with cancer predisposition genodermatosis: a role for confocal microscopy and photodynamic therapy","volume":"25","author":"Segura","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ejca.2023.113254_bib67","article-title":"Reflectance confocal microscopy follow-up of multifocal superficial basal cell carcinomas treated with imiquimod 5% cream","volume":"12","author":"Zou","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.ejca.2023.113254_bib68","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/bjd.17201","article-title":"The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review","volume":"180","author":"Reddy","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib69","article-title":"Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults","volume":"12","author":"Ferrante di Ruffano","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2023.113254_bib70","article-title":"Diagnostic value of optical coherence tomography image features for diagnosis of basal cell carcinoma","volume":"101","author":"Adan","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib71","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(22)00347-3","article-title":"Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trial","volume":"23","author":"Adan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib72","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamadermatol.2018.2446","article-title":"Evaluation of a combined reflectance confocal microscopy-optical coherence tomography device for detection and depth assessment of basal cell carcinoma","volume":"154","author":"Sahu","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/cup.13871","article-title":"Angulated small nests and cords: key diagnostic histopathologic features of infiltrative basal cell carcinoma can be identified using integrated reflectance confocal microscopy-optical coherence tomography","volume":"48","author":"Gill","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2023.113254_bib74","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaad.2019.10.028","article-title":"Presurgical evaluation of basal cell carcinoma using combined reflectance confocal microscopy-optical coherence tomography: a prospective study","volume":"82","author":"Aleissa","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib75","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jdv.17078","article-title":"Line-field confocal optical coherence tomography of basal cell carcinoma: a descriptive study","volume":"35","author":"Suppa","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib76","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/ced.14762","article-title":"Line-field optical coherence tomography: in vivo diagnosis of basal cell carcinoma subtypes compared with histopathology","volume":"46","author":"Ruini","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib77","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.3390\/cancers13194913","article-title":"Line-field confocal optical coherence tomography may enhance monitoring of superficial basal cell carcinoma treated with imiquimod 5% cream: a pilot study","volume":"13","author":"Verz\u00ec","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2023.113254_bib78","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/diagnostics13030361","article-title":"Diagnostic accuracy of line-field confocal optical coherence tomography for the diagnosis of skin carcinomas","volume":"13","author":"Cinotti","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejca.2023.113254_bib79","series-title":"WHO classification of skin tumors","author":"Elder","year":"2018"},{"key":"10.1016\/j.ejca.2023.113254_bib80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jdv.17849","article-title":"Position paper on a simplified histopathological classification of basal cell carcinoma: results of the European Consensus Project","volume":"36","author":"Fern\u00e1ndez-Figueras","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib81","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djn260","article-title":"Nonmelanoma skin cancer and risk for subsequent malignancy","volume":"100","author":"Chen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2023.113254_bib82","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/jdv.17155","article-title":"Three-dimensional histology vs. serial section histology in the treatment of primary basal cell carcinoma: a randomized, prospective, blinded study of 569 tumours","volume":"35","author":"Kofler","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/bjd.19809","article-title":"Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments","volume":"185","author":"Thomson","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib84","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/jdv.18048","article-title":"Recurrence rate of basal cell carcinoma among different micrographic surgery techniques: systematic review with meta-analysis","volume":"36","author":"Lacerda","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib85","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/DSS.0000000000003462","article-title":"Complete margin assessment versus sectional assessment in surgically excised high-risk keratinocyte carcinomas: a systematic review and meta-analysis","volume":"48","author":"Fraga","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib86","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1111\/jdv.15796","article-title":"Comparing treatments for basal cell carcinoma in terms of long-term treatment-failure: a network meta-analysis","volume":"33","author":"Fukumoto","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib87","first-page":"37","article-title":"A review of the global guidelines on surgical margins for nonmelanoma skin cancers","volume":"1","author":"Nahhas","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib88","first-page":"214","article-title":"S2k guidelines for cutaneous basal cell carcinoma - part 2: treatment, prevention and follow-up","volume":"17","author":"Lang","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2023.113254_bib89","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/PRS.0b013e3181ea450d","article-title":"What is the best surgical margin for a Basal cell carcinoma: a meta-analysis of the literature","volume":"126","author":"Gulleth","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00128071-200203040-00003","article-title":"Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy","volume":"3","author":"Kuijpers","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib91","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/jdv.12689","article-title":"Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan","volume":"29","author":"Ito","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib92","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7682917","article-title":"Treatment of pigmented basal cell carcinoma with 3\u2009mm surgical margin in Asians","volume":"2016","author":"Lin","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejca.2023.113254_bib93","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7181\/acfs.2021.00206","article-title":"Does reduction of the oncologic safety margin for facial basal cell carcinoma result in higher recurrence rates?","volume":"22","author":"Kim","year":"2021","journal-title":"Arch Craniofac Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib94","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/diagnostics11010120","article-title":"Preoperative evaluation through dermoscopy and reflectance confocal microscopy of the lateral excision margins for primary basal cell carcinoma","volume":"11","author":"Lupu","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejca.2023.113254_bib95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1600-0560.2007.00943.x","article-title":"Shrinkage of cutaneous specimens: formalin or other factors involved?","volume":"35","author":"Kerns","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2023.113254_bib96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/cup.12401","article-title":"Study of shrinkage of cutaneous surgical specimens","volume":"42","author":"Blasco-Morente","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2023.113254_bib97","first-page":"942","article-title":"S1 guideline: microscopically controlled surgery (MCS)","volume":"13","author":"L\u00f6ser","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2023.113254_bib98","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib99","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up","volume":"50","author":"van Loo","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib100","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bjps.2015.03.012","article-title":"Reconstructive outcomes of Mohs surgery compared with conventional excision: a 13-month prospective study","volume":"68","author":"Wain","year":"2015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib101","article-title":"Mohs micrographic surgery versus standard excision for basal cell carcinoma in the head and neck: systematic review and meta-analysis","volume":"13","author":"Alsaif","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ejca.2023.113254_bib102","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","volume":"67","author":"Ad Hoc Task Force","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib103","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/bjd.14308","article-title":"Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread","volume":"174","author":"Hoorens","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13474","article-title":"It's time for Mohs: micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions","volume":"33","author":"Dika","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ejca.2023.113254_bib105","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/ced.15266","article-title":"A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma","volume":"47","author":"Brown","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib106","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-4725.1992.tb03307.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision","volume":"18","author":"Silverman","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib107","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib108","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/coa.13176","article-title":"Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: a retrospective study of 1021 cases","volume":"43","author":"Kuiper","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.ejca.2023.113254_bib109","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/DSS.0000000000000394","article-title":"Long-term follow-up of positive surgical margins in basal cell carcinoma of the face","volume":"41","author":"Bozan","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib110","first-page":"145","article-title":"Basal cell carcinoma incompletely excised: a case-control study on recurrence","volume":"151","author":"Borghi","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib111","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bjps.2015.12.024","article-title":"Basal cell carcinomata: risk factors for incomplete excision and results of re-excision","volume":"69","author":"Masud","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib112","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1111\/jdv.16327","article-title":"Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision","volume":"34","author":"Kappelin","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.ejca.2023.113254_bib113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000529367","article-title":"Real-life data on the management of incompletely excised basal cell carcinoma","volume":"239","author":"Daviti","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2023.113254_bib114","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.19660","article-title":"Incomplete surgical excision of keratinocyte skin cancers: a systematic review and meta-analysis","volume":"184","author":"Nolan","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2004.06135.x","article-title":"Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions","volume":"151","author":"Boulinguez","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib116","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1524-4725.1991.tb03424.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 1: overview","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib117","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2006.07.007","article-title":"Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation","volume":"56","author":"Rodriguez-Vigil","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib118","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.abd.2020.12.011","article-title":"Curettage and electrocoagulation versus surgical excision in the treatment of low-risk basal cell carcinoma - Postoperative follow-up and satisfaction at three months: randomized clinical trial","volume":"97","author":"Bastos","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib119","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib120","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/DSS.0000000000001106","article-title":"Pulsed CO2 laser ablation of superficial basal cell of limbs and trunk: a comparative randomized clinical trial with cryotherapy and surgical ablation","volume":"43","author":"Zane","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib121","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/jdv.18209","article-title":"Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial","volume":"36","author":"Backman","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib122","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib123","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jdv.14989","article-title":"Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode","volume":"32","author":"Genouw","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib124","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.16838","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis","volume":"179","author":"Collier","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib125","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8\u201320\u2009mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib126","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib127","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lsm.23041","article-title":"Outcomes of long-pulsed 1064\u2009nm Nd:YAG laser treatment of basal cell carcinoma: a retrospective review","volume":"51","author":"Ahluwalia","year":"2019","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2023.113254_bib128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/lsm.23455","article-title":"Combining Nd:YAG laser with optical coherence tomography for nonsurgical treatment of basal cell carcinoma","volume":"54","author":"Markowitz","year":"2022","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2023.113254_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/lsm.22803","article-title":"An expanded study of long-pulsed 1064\u2009nm Nd:YAG laser treatment of basal cell carcinoma","author":"Ortiz","year":"2018","journal-title":"Lasers Surg Med"},{"issue":"3","key":"10.1016\/j.ejca.2023.113254_bib130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/lsm.23638","article-title":"Optical coherence tomography-guided Nd:YAG laser treatment and follow-up of basal cell carcinoma","volume":"55","author":"Kranz","year":"2023","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2023.113254_bib131","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib132","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jid.2016.03.043","article-title":"Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial","volume":"136","author":"Roozeboom","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib133","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib134","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaad.2015.03.048","article-title":"Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU)","volume":"73","author":"Roozeboom","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1203475420931770","article-title":"Topical imiquimod as a treatment option for nodular basal cell carcinoma: a systematic review","volume":"24","author":"Huang","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib136","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib137","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jid.2016.10.019","article-title":"Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial","volume":"137","author":"Williams","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib138","article-title":"Interventions for basal cell carcinoma of the skin","volume":"11","author":"Thomson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ejca.2023.113254_bib139","doi-asserted-by":"crossref","first-page":"979.e1","DOI":"10.1016\/j.jaad.2013.12.037","article-title":"Topical pharmacotherapy for skin cancer: part II. Clinical applications","volume":"70","author":"Micali","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-022-00731-x","article-title":"Advances in topical treatments of cutaneous malignancies","volume":"24","author":"Algarin","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib141","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.3390\/molecules25225398","article-title":"Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities","volume":"25","author":"Collier","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejca.2023.113254_bib142","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bjd.17309","article-title":"British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018","volume":"180","author":"Wong","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib143","first-page":"309","article-title":"A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy","volume":"179","author":"Morton","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib144","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.clon.2009.03.004","article-title":"Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas","volume":"2","author":"Loncaster","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ejca.2023.113254_bib145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial","volume":"92","author":"de Vijlder","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib146","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1159\/000524745","article-title":"Long-term efficacy of photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus conventional two-stage topical methyl aminolevulinate for superficial basal-cell carcinoma","volume":"238","author":"van Delft","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2023.113254_bib147","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib148","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/lsm.20606","article-title":"Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma","volume":"40","author":"Smucler","year":"2008","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2023.113254_bib149","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/SAP.0b013e3182773ed2","article-title":"Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma","volume":"73","author":"Shokrollahi","year":"2014","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1308\/rcsann.2020.7020","article-title":"Treatment of cutaneous basal cell carcinoma with combined laser extirpation and methyl aminolevulinic acid: five-year success rates","volume":"103","author":"Azzopardi","year":"2021","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.ejca.2023.113254_bib151","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3892\/ol.2013.1504","article-title":"Photodynamic therapy combined with cryotherapy for the treatment of nodular basal cell carcinoma","volume":"6","author":"Kim","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2023.113254_bib152","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/lsm.23497","article-title":"Efficacy and safety of laser-assisted combination chemotherapy: a follow-up study of treatment with 5-fluorouracil and cisplatin for basal cell carcinoma","volume":"54","author":"Fredman","year":"2022","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.ejca.2023.113254_bib153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/phpp.12313","article-title":"Methyl aminolevulinate photodynamic therapy combined with curettage debulking for pigmented basal cell carcinoma","volume":"33","author":"Gracia-Caza\u00f1a","year":"2017","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1 Suppl 1","key":"10.1016\/j.ejca.2023.113254_bib154","first-page":"s7","article-title":"A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma","volume":"7","author":"Tillman","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaad.2020.04.053","article-title":"Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: one-year results of a noninferiority, randomized, controlled trial","volume":"83","author":"Sinx","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib156","doi-asserted-by":"crossref","first-page":"25912","DOI":"10.3390\/ijms161025912","article-title":"Combined treatments with photodynamic therapy for non-melanoma skin cancer","volume":"16","author":"Lucena","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2023.113254_bib157","doi-asserted-by":"crossref","first-page":"PI5","DOI":"10.12659\/MSM.882449","article-title":"The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma","volume":"18","author":"Osiecka","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejca.2023.113254_bib158","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1468-3083.2011.04177.x","article-title":"A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod","volume":"26","author":"Messeguer","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib159","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/diseases9040071","article-title":"A review of immunocryosurgery and a practical guide to its applications","volume":"9","author":"Gaitanis","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.ejca.2023.113254_bib160","first-page":"1462","article-title":"5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma","volume":"30","author":"Torres","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib161","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1524-4725.2009.01464.x","article-title":"Letter: imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study","volume":"36","author":"Moehrle","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib162","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4103\/jcrt.JCRT_987_19","article-title":"Clinical efficacy of Mohs surgery combined with topical photodynamic therapy for facial basal cell carcinoma","volume":"16","author":"Zhang","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ejca.2023.113254_bib163","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M18-0678","article-title":"Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis","volume":"169","author":"Drucker","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejca.2023.113254_bib164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2018.01.013","article-title":"GEC-ESTRO ACROP recommendations in skin brachytherapy","volume":"126","author":"Guinot","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.5114\/jcb.2015.56465","article-title":"Brachytherapy in non melanoma skin cancer of eyelid: a systematic review","volume":"7","author":"Frakulli","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.ejca.2023.113254_bib166","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/lary.25498","article-title":"Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas","volume":"126","author":"Bussu","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejca.2023.113254_bib167","doi-asserted-by":"crossref","first-page":"516","DOI":"10.5301\/tj.5000614","article-title":"Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review","volume":"103","author":"Tagliaferri","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.ejca.2023.113254_bib168","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","article-title":"GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology","volume":"122","author":"Kov\u00e1cs","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib169","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2017.08.011","article-title":"Hypofractionated radiation therapy for basal and squamous cell skin cancer: a meta-analysis","volume":"125","author":"Zaorsky","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejca.2020.06.020","volume":"138","author":"Clover","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib171","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.3390\/curroncol29080423","article-title":"Treatment of basal cell carcinoma with electrochemotherapy: insights from the InspECT Registry (2008-2019)","volume":"29","author":"Bertino","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib172","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ejso.2019.11.509","article-title":"Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up","volume":"46","author":"Clover","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100844","article-title":"Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: first results of a multicenter, open-label, phase 2 trial (VISMONEO study): neoadjuvant vismodegib in locally advanced basal cell carcinoma","volume":"35","author":"Bertrand","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejca.2023.113254_bib174","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/DDDT.S325852","article-title":"Current perspectives in the treatment of locally advanced basal cell carcinoma","volume":"16","author":"Gupta","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejca.2023.113254_bib175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.21037\/apm.2016.11.10","article-title":"Palliative radiotherapy for skin malignancies","volume":"6","author":"Vuong","year":"2017","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ejca.2023.113254_bib176","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25602-7","article-title":"Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project)","volume":"12","author":"Donati","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2023.113254_bib177","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/lary.20608","article-title":"Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck","volume":"119","author":"Mendenhall","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejca.2023.113254_bib178","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jgo.2018.09.009","article-title":"The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer","volume":"10","author":"Lancellotta","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib179","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.annder.2019.08.019","article-title":"Synergie de la s\u00e9quence immunoth\u00e9rapie par anti-PD1 et radioth\u00e9rapie au cours d\u2019un carcinome basocellulaire avanc\u00e9 [Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma]","volume":"147","author":"Malmontet","year":"2020","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib180","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1002\/onco.13959","article-title":"Hedgehog inhibitor induction with addition of concurrent superficial radiotherapy in patients with locally advanced basal cell carcinoma: a case series","volume":"26","author":"Weissman","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2023.113254_bib181","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113254_bib182","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3286-5","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib183","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2017.08.022","article-title":"Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial","volume":"86","author":"Basset-S\u00e9guin","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib184","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib185","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/bjd.18552","article-title":"Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study","volume":"182","author":"Dummer","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib186","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S1470-2045(16)30566-6","article-title":"Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"17","author":"Tang","year":"2016","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2023.113254_bib187","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.3390\/cancers14215469","article-title":"Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients","volume":"14","author":"DeTemple","year":"2022","journal-title":"Cancers ((Basel))"},{"issue":"3","key":"10.1016\/j.ejca.2023.113254_bib188","doi-asserted-by":"crossref","DOI":"10.1007\/s40257-023-00763-x","article-title":"Efficacy and safety of sonic hedgehog inhibitors in basal cell carcinomas: an updated systematic review and meta-analysis (2009-2022)","volume":"24","author":"Nguyen","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib189","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1634\/theoncologist.2016-0186","article-title":"Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma","volume":"21","author":"Lacouture","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2023.113254_bib190","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.18632\/oncotarget.28145","article-title":"Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma","volume":"12","author":"Lear","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2023.113254_bib191","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.ejca.2023.113254_bib192","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jaad.2022.11.044","article-title":"Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids","volume":"88","author":"Kreher","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib193","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","article-title":"Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial","volume":"22","author":"Stratigos","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib194","first-page":"77","article-title":"Treatments of advanced basal cell carcinoma: a review of the literature","volume":"151","author":"Peris","year":"2016","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib195","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/annonc\/mdy228","article-title":"Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide","volume":"29","author":"Scott\u00e9","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib196","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib197","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ejca.2023.113254_bib198","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","article-title":"Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases","volume":"57","author":"Gehl","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib199","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jpainsymman.2009.11.319","article-title":"A systematic review of topical treatments to control the odor of malignant fungating wounds","volume":"39","author":"da Costa Santos","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ejca.2023.113254_bib200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/WON.0000000000000460","article-title":"Polyhexanide versus metronidazole for odor management in malignant (fungating) wounds: a double-blinded, randomized, clinical trial","volume":"45","author":"Villela-Castro","year":"2018","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"10.1016\/j.ejca.2023.113254_bib201","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ASW.0000383206.32244.e2","article-title":"Local wound care for malignant and palliative wounds","volume":"23","author":"Woo","year":"2010","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.ejca.2023.113254_bib202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","article-title":"Management of bleeding in patients with advanced cancer","volume":"9","author":"Pereira","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.ejca.2023.113254_bib203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamadermatol.2022.4590","article-title":"Follow-up of patients with keratinocyte carcinoma: a systematic review of clinical practice guidelines","volume":"159","author":"Mirali","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib204","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jdv.14587","article-title":"Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009","volume":"32","author":"van der Leest","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2023.113254_bib206","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bjd.16900","article-title":"Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study","volume":"180","author":"van Egmond","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib207","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Work Group; Invited Reviewers","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib208","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bjps.2017.04.006","article-title":"Risk factors for recurrence of facial basal cell carcinoma after surgical excision: a follow-up analysis","volume":"70","author":"Armstrong","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib209","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2011.10488.x","article-title":"Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands","volume":"165","author":"Flohil","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","article-title":"Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma","volume":"151","author":"Wehner","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib211","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10689-018-0073-7","article-title":"Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same","volume":"17","author":"Huq","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib212","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/ajmg.a.34128","article-title":"Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS)","volume":"155A","author":"Bree","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejca.2023.113254_bib213","doi-asserted-by":"crossref","DOI":"10.1186\/s40902-022-00355-5","article-title":"Multidisciplinary approach to Gorlin-Goltz syndrome: from diagnosis to surgical treatment of jawbones","volume":"44","author":"Spadari","year":"2022","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.ejca.2023.113254_bib214","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.20700","article-title":"A guideline for the clinical management of basal cell naevus syndrome (Gorlin-Goltz syndrome)","volume":"186","author":"Verkouteren","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib215","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10689-021-00247-z","article-title":"Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)","volume":"20","author":"Guerrini-Rousseau","year":"2021","journal-title":"Fam Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib216","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2017-104669","article-title":"First evidence of genotype-phenotype correlations in Gorlin syndrome","volume":"54","author":"Evans","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejca.2023.113254_bib217","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1200\/JCO.21.02385","article-title":"Gorlin syndrome: assessing genotype-phenotype correlations and analysis of early clinical characteristics as risk factors for disease severity","volume":"40","author":"Betancourt","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib218","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jaad.2006.08.039","article-title":"Basal cell carcinoma on the trunk is associated with excessive sun exposure","volume":"56","author":"Neale","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib219","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.2013-3559","article-title":"Early-onset basal cell carcinoma and indoor tanning: a population-based study","volume":"134","author":"Karagas","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejca.2023.113254_bib220","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib221","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archdermatol.2010.155","article-title":"Risk factors for single and multiple basal cell carcinomas","volume":"146","author":"Kiiski","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib222","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ajcn\/nqaa127","article-title":"Mediterranean diet, Dietary Approaches to Stop Hypertension, and Pro-vegetarian dietary pattern in relation to the risk of basal cell carcinoma: a nested case-control study within the Seguimiento Universidad de Navarra (SUN) cohort","volume":"112","author":"Leone","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2023.113254_bib223","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1158\/0008-5472.CAN-11-3511","article-title":"Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin","volume":"72","author":"Song","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2023.113254_bib224","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/annonc\/mdp286","article-title":"Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials","volume":"21","author":"Myung","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113254_bib225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib226","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113254_bib227","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.113254_bib228","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaad.2015.08.034","article-title":"Can oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis","volume":"74","author":"Muranushi","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib229","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2023.113254_bib230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1940-6207.CAPR-13-0305","article-title":"Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome","volume":"7","author":"Tang","year":"2014","journal-title":"Cancer Prev Res"},{"issue":"12","key":"10.1016\/j.ejca.2023.113254_bib231","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/DAD.0000000000002321","article-title":"Basal cell carcinomas after radiotherapy show more frequent follicular differentiation than tumors from sun-exposed areas: immunohistochemical study with a special focus on infundibulocystic basal cell carcinoma","volume":"44","author":"Cardoso","year":"2022","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.ejca.2023.113254_bib232","doi-asserted-by":"crossref","first-page":"237","DOI":"10.6004\/jnccn.2018.7096","article-title":"Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy","volume":"17","author":"Thorsness","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2023.113254_bib233","article-title":"The relationship between vitamin D and basal cell carcinoma: a systematic review","volume":"14","author":"Abdelwahab","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.ejca.2023.113254_bib234","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/1097-0142(20010715)92:2<354::AID-CNCR1330>3.0.CO;2-F","article-title":"Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck","volume":"92","author":"Ramachandran","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113254_bib235","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jaad.2015.08.073","article-title":"Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors","volume":"74","author":"Jaju","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923003568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:41:35Z","timestamp":1760733695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923003568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":235,"alternative-id":["S0959804923003568"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113254","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma\u2014update 2023","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113254"}}